Forecasted · Cooperative Agreement
Expanded Surveillance for Pediatric Infectious Diseases
Centers for Disease Control and Prevention - ERA, Department of Health and Human Services
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- Expanded Surveillance for Pediatric Infectious Diseases
- Issuing agency
- Centers for Disease Control and Prevention - ERA (Department of Health and Human Services)
- Opportunity number
- RFA-IP-27-035
- Funding type
- Cooperative Agreement
- Funding purpose
- Health
- Status
- Forecasted
- Application deadline
- Forecasted · estimated close December 31, 2026 (agency estimate)Agency note: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
- Agency estimates
- Estimated posting: October 30, 2026. Estimated award date: July 30, 2027. Estimates can change.
- Published award range
- $850,000 – $1,140,000
- Estimated total program funding
- $40,000,000
- Expected number of awards
- 7
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 93.083
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/363342 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 363342 · Funding opportunity number RFA-IP-27-035
- Posted
- July 28, 2026 · Source last updated July 29, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 92% of key fields published by the sourceNot published: eligibility criteria text.
- Record confidence
- mediumforecast — dates and amounts are agency estimates.
Description (from the official listing)
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.Component A – Core Component (Required)Support inpatient and emergency department pediatric surveillanceFollow the standardized protocol established by CDCOptional ComponentsComponent B: Support outpatient pediatric surveillanceComponent C: Study immune response and infectionComponent D: Study immune response and immunizationRecipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the…
Read the full description
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.Component A – Core Component (Required)Support inpatient and emergency department pediatric surveillanceFollow the standardized protocol established by CDCOptional ComponentsComponent B: Support outpatient pediatric surveillanceComponent C: Study immune response and infectionComponent D: Study immune response and immunizationRecipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.Findings of this NOFO will:Improve best practices for diagnosis and treatment protocolsInform prevention product recommendationsGuide public health strategiesReduce viral illness-associated hospitalizations and healthcare utilization among children
Agency contact
Jamal Bankhead
JBankhead@cdc.gov